Tan Kevin 4
4 · Solid Biosciences Inc. · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
Solid Biosciences (SLDB) CFO Kevin Tan Sells 26,837 Shares
What Happened
- Kevin Tan, CFO & Treasurer of Solid Biosciences (SLDB), sold 26,837 shares on Feb 2, 2026 at a weighted-average price of $6.44, generating approximately $172,747. The sale was a sell-to-cover to satisfy tax withholding following the vesting/conversion of performance units.
- Related entries show conversions/exercises of derivatives on Jan 29 (56,646 shares) and Jan 31 (33,075 shares), and grant/award entries on Jan 29 for 187,000 and 93,500 derivative units (PSUs/RSUs) that convert one-for-one to common shares. The PSU vesting was triggered by a board-certified performance milestone on Jan 29, 2026 (25% of the PSU target vested).
Key Details
- Transaction dates and prices: Jan 29, 2026 (conversion/exercise entries), Jan 31, 2026 (conversion/exercise entries), Feb 2, 2026 sale at weighted avg $6.44 (individual sale prices ranged $6.295–$6.58).
- Shares sold: 26,837; proceeds ≈ $172,747. Conversions/exercises reported: 56,646 and 33,075 shares. Awards reported on Jan 29: 187,000 and 93,500 PSUs/RSUs.
- Shares owned after the transactions: not specified in the provided filing excerpt.
- Notable footnotes: the Feb 2 sale was an automatic sell-to-cover for withholding taxes (non-discretionary) per Mr. Tan’s durable instruction; PSUs convert 1:1 to common stock and 25% vested upon meeting a specified performance milestone on Jan 29, 2026; sale price reported is a weighted average and covered multiple execution prices.
- Filing timing: Form 4 filed Feb 2, 2026 reporting transactions through Jan 29, 2026; the filing is not marked as late.
Context
- These entries reflect awards vesting and derivative conversions, not an open-market, discretionary sell motivated by trade timing. The sale was to cover taxes on vested PSUs (a routine, non-discretionary sell-to-cover). For retail investors, awards and vesting are informative about compensation and dilution; purchases would be a stronger bullish signal.
Insider Transaction Report
Form 4
Tan Kevin
CFO & Treasurer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-29+56,646→ 102,746 total - Exercise/Conversion
Common Stock
[F2]2026-01-31+33,075→ 135,821 total - Sale
Common Stock
[F3][F4]2026-02-02$6.44/sh−26,837$172,747→ 108,984 total - Exercise/Conversion
Performance Stock Units
[F1][F5]2026-01-29−56,646→ 0 total→ Common Stock (56,646 underlying) - Award
Employee Stock Option (Right to Buy)
[F6]2026-01-29+187,000→ 187,000 totalExercise: $6.60Exp: 2036-01-29→ Common Stock (187,000 underlying) - Award
Restricted Stock Units
[F2][F7]2026-01-29+93,500→ 93,500 total→ Common Stock (93,500 underlying) - Exercise/Conversion
Restricted Stock Units
[F2][F8]2026-01-31−33,075→ 99,225 total→ Common Stock (33,075 underlying)
Footnotes (8)
- [F1]Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis.
- [F2]Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis.
- [F3]This sale was made to cover withholding taxes following the vesting of previously granted PSUs pursuant to a durable automatic sale instruction letter adopted by Mr. Tan on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Tan.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.295 to $6.580, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form.
- [F5]The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares.
- [F6]This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.
- [F7]The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary.
- [F8]On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 132,300 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary.
Signature
/s/ Kimberly Cornwell as attorney-in-fact for Kevin Tan|2026-02-02